Gene · 6368
Papers1,587
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
201 to 220 of 1,587
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| A Microenvironment-Related Nine-Gene Signature May Predict Survival in Mycosis Fungoides Patients at Diagnosis. | Cells | 2023 | 37566023 | PubTator, text mining | PubMed |
| Dissecting human population variation in single-cell responses to SARS-CoV-2. | Nature | 2023 | 37558883 | PubTator, text mining | PubMed |
| Integrated bioinformatics analyses identifying potential biomarkers for type 2 diabetes mellitus and breast cancer: In SIK1-ness and health. | PLoS One | 2023 | 37556419 | PubTator, text mining | PubMed |
| Intestinal Immune Imbalance is an Alarm in the Development of IBD. | Mediators Inflamm | 2023 | 37554552 | PubTator, text mining | PubMed |
| Effects of Short- And Medium-Term Exposures to Lower Air Temperature on 71 Novel Biomarkers of Subclinical Inflammation: Results from the KORA F4 Study. | Environ Sci Technol | 2023 | 37552838 | PubTator, text mining | PubMed |
| From Teeth to Therapy: A Review of Therapeutic Potential within the Secretome of Stem Cells from Human Exfoliated Deciduous Teeth. | Int J Mol Sci | 2023 | 37511524 | PubTator, text mining | PubMed |
| Interleukin 5 Receptor Subunit Alpha Expression as a Potential Biomarker in Patients with Nasal Polyposis. | Biomedicines | 2023 | 37509606 | PubTator, text mining | PubMed |
| Plasma proteomic profiling identifies CD33 as a marker of HIV control in natural infection and after therapeutic vaccination. | EBioMedicine | 2023 | 37506557 | PubTator, text mining | PubMed |
| A phase 1 study of nivolumab in combination with interferon-gamma for patients with advanced solid tumors. | Nat Commun | 2023 | 37500647 | PubTator, text mining | PubMed |
| Peripheral blood inflammatory cytokines in prodromal and overt α-synucleinopathies: a review of current evidence. | Encephalitis | 2023 | 37500099 | PubTator, text mining | PubMed |
| The interaction of macrophages and CD8 T cells in bronchoalveolar lavage fluid is associated with latent tuberculosis infection. | Emerg Microbes Infect | 2023 | 37470432 | PubTator, text mining | PubMed |
| The application of Aptamer in biomarker discovery. | Biomark Res | 2023 | 37468977 | PubTator, text mining | PubMed |
| Immune suppressive microenvironment in liver metastases contributes to organ-specific response of immunotherapy in advanced non-small cell lung cancer. | J Immunother Cancer | 2023 | 37463790 | PubTator, text mining | PubMed |
| Engineering broad-spectrum inhibitors of inflammatory chemokines from subclass A3 tick evasins. | Nat Commun | 2023 | 37452046 | PubTator, text mining | PubMed |
| Diseases from the Spectrum of Dermatitis and Eczema: Can "Omics" Sciences Help with Better Systematics and More Accurate Differential Diagnosis? | Int J Mol Sci | 2023 | 37445645 | PubTator, text mining | PubMed |
| New Insights in the Era of Clinical Biomarkers as Potential Predictors of Systemic Therapy-Induced Cardiotoxicity in Women with Breast Cancer: A Systematic Review. | Cancers (Basel) | 2023 | 37444400 | PubTator, text mining | PubMed |
| Epithelial-mesenchymal transition-related gene signature for prognosis of lung squamous cell carcinoma. | Medicine (Baltimore) | 2023 | 37443495 | PubTator, text mining | PubMed |
| A genetic regulatory see-saw of biofilm and virulence in MRSA pathogenesis. | Front Microbiol | 2023 | 37434702 | PubTator, text mining | PubMed |
| Machine learning for prediction of immunotherapeutic outcome in non-small-cell lung cancer based on circulating cytokine signatures. | J Immunother Cancer | 2023 | 37433717 | PubTator, text mining | PubMed |
| Imbalance of Vaginal Microbiota and Immunity: Two Main Accomplices of Cervical Cancer in Chinese Women. | Int J Womens Health | 2023 | 37424699 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/6368/papers?page=11